Kisqali (Ribociclib) is an advanced cancer treatment classified as a CDK4\/6 inhibitor<\/strong>. It is primarily prescribed for women with HR-positive, HER2-negative advanced or metastatic breast cancer<\/strong>. Kisqali is used in combination with hormonal therapies<\/strong> such as letrozole<\/strong> or fulvestrant<\/strong> to improve survival rates and slow down cancer progression.<\/p>\n Treatment of advanced breast cancer<\/strong> in women.<\/p>\n<\/li>\n Used with endocrine therapy<\/strong> like aromatase inhibitors or fulvestrant.<\/p>\n<\/li>\n Helps prevent further progression of tumors.<\/p>\n<\/li>\n Improves overall survival in HR+\/HER2- breast cancer patients.<\/p>\n<\/li>\n<\/ul>\n Kisqali contains Ribociclib<\/strong>, which inhibits cyclin-dependent kinases 4 and 6 (CDK4\/6)<\/strong>. These enzymes regulate cell division.<\/p>\n By blocking them, the drug halts cancer cell growth<\/strong>.<\/p>\n<\/li>\n This slows down or completely stops tumor development.<\/p>\n<\/li>\n Unlike chemotherapy, it targets cancer cell mechanisms more selectively, reducing damage to healthy cells.<\/p>\n<\/li>\n<\/ul>\n Recommended dose: 600 mg daily<\/strong> (3 tablets of 200 mg).<\/p>\n<\/li>\n Taken for 21 consecutive days<\/strong>, followed by 7 days off<\/strong> (28-day cycle).<\/p>\n<\/li>\n Tablets should be taken at the same time each day, with or without food.<\/p>\n<\/li>\n Tablets must be swallowed whole \u2013 not crushed or broken.<\/p>\n<\/li>\n<\/ul>\n ⚠️ Patients must follow the doctor\u2019s prescription strictly. Dose adjustments may be needed based on lab results and tolerance.<\/p>\n Like all cancer treatments, Kisqali may cause side effects:<\/p>\n Nausea and vomiting.<\/p>\n<\/li>\n Diarrhea or constipation.<\/p>\n<\/li>\n Fatigue and headache.<\/p>\n<\/li>\n Loss of appetite.<\/p>\n<\/li>\n Mild hair thinning.<\/p>\n<\/li>\n Blood count changes (low white cells or platelets).<\/p>\n<\/li>\n Elevated liver enzymes.<\/p>\n<\/li>\n<\/ul>\n Serious side effects: irregular heartbeat, severe infections, or liver problems<\/strong>. Immediate medical attention is required in such cases.<\/p>\n Allergy to ribociclib or tablet ingredients.<\/p>\n<\/li>\n Pregnant and breastfeeding women.<\/p>\n<\/li>\n Severe liver disease.<\/p>\n<\/li>\n Patients with heart rhythm disorders (QT prolongation<\/strong>).<\/p>\n<\/li>\n<\/ul>\n Kisqali can interact with several medicines, including:<\/p>\n Antibiotics (clarithromycin, erythromycin).<\/p>\n<\/li>\n Antifungals (ketoconazole, itraconazole).<\/p>\n<\/li>\n Heart medicines (amiodarone, verapamil).<\/p>\n<\/li>\n Statins (cholesterol-lowering drugs).<\/p>\n<\/li>\n Herbal supplements like St. John\u2019s Wort<\/strong>.<\/p>\n<\/li>\n<\/ul>\n Always inform your doctor about all medications and supplements before starting Kisqali.<\/p>\n Regular blood tests<\/strong> are required to monitor liver function and blood counts.<\/p>\n<\/li>\n Avoid grapefruit and its juice<\/strong> (increases drug levels in the blood).<\/p>\n<\/li>\n Not safe during pregnancy \u2013 use effective birth control.<\/p>\n<\/li>\n Stop breastfeeding during treatment.<\/p>\n<\/li>\n<\/ul>\n ⭐⭐⭐⭐⭐ \u201cKisqali made a huge difference in my treatment plan, with manageable side effects.\u201d<\/p>\n<\/li>\n ⭐⭐⭐⭐\u2606 \u201cEffective but requires constant monitoring of blood counts.\u201d<\/p>\n<\/li>\n ⭐⭐⭐⭐⭐ \u201cExcellent results in combination with hormonal therapy, very satisfied.\u201d<\/p>\n<\/li>\n<\/ul>\n 1. What is Kisqali used for?<\/strong> 2. How does Ribociclib work in cancer treatment?<\/strong> 3. What is the recommended dosage?<\/strong> 4. Can it be taken with food?<\/strong> 5. What are the serious side effects?<\/strong> 6. Does Kisqali cause hair loss?<\/strong> 7. Can pregnant women take Kisqali?<\/strong> 8. How long before results are seen?<\/strong> 9. Can it be combined with other drugs?<\/strong> 10. What are alternatives if Kisqali is unavailable?<\/strong> <\/p>\n
\nIndications (Medical Uses)<\/h2>\n
\n
\nHow Does Kisqali Work?<\/h2>\n
\n
\nDosage and Administration<\/h2>\n
\n
\nPossible Side Effects<\/h2>\n
\n
\nContraindications<\/h2>\n
\n
\nDrug Interactions<\/h2>\n
\n
\nPrecautions & Warnings<\/h2>\n
\n
\n⭐ User Reviews<\/h2>\n
\n
\n❓ Frequently Asked Questions (FAQs)<\/h2>\n
It treats advanced or metastatic breast cancer (HR+\/HER2-).<\/p>\n
It blocks CDK4\/6 enzymes, stopping cancer cell growth.<\/p>\n
600 mg daily (3 tablets of 200 mg) for 21 days, followed by 7 days off.<\/p>\n
Yes, with or without food, preferably at the same time each day.<\/p>\n
Liver damage, irregular heartbeat, and severe infections.<\/p>\n
It may cause mild hair thinning, but not severe like chemotherapy.<\/p>\n
No, it is unsafe during pregnancy and breastfeeding.<\/p>\n
Response varies, usually noticeable after 8\u201312 weeks.<\/p>\n
Yes, often combined with letrozole or fulvestrant, but drug interactions must be checked.<\/p>\n
Other CDK4\/6 inhibitors like Ibrance (Palbociclib)<\/strong> and Verzenio (Abemaciclib)<\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"\n\n
\n Name<\/th>\n Kisqali 200 mg<\/td>\n<\/tr>\n \n Brand<\/th>\n Novartis<\/td>\n<\/tr>\n \n Strength<\/th>\n 200 mg<\/td>\n<\/tr>\n \n Quantity \/ Size<\/th>\n 63 film-coated tablets<\/td>\n<\/tr>\n \n Form<\/th>\n Oral tablets<\/td>\n<\/tr>\n \n Appearance<\/th>\n Carton box with blister packs<\/td>\n<\/tr>\n \n Expiry Date<\/th>\n Printed on the package<\/td>\n<\/tr>\n \n Country of Origin<\/th>\n Switzerland \/ Germany<\/td>\n<\/tr>\n \n Product Code<\/th>\n [Insert official barcode\/serial code]<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n